Peter Sordillo
Hoofd Techniek/Wetenschap/O&O bij SignPath Pharma, Inc.
Profiel
Peter Sordillo is currently the Chief Medical Officer, Chief Science Officer & VP at SignPath Pharma, Inc. and an Associate Professor at Icahn School of Medicine at Mount Sinai.
He previously worked as an Assistant Professor at Weill Cornell Medical College and an Associate Professor at New York University School of Medicine.
Dr. Sordillo has a graduate and doctorate degree from The Trustees of Columbia University in The City of New York, a graduate degree from New York University, a graduate degree from New York Medical College, and an undergraduate degree from Columbia College (New York).
Actieve functies van Peter Sordillo
Bedrijven | Functie | Begin |
---|---|---|
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Hoofd Techniek/Wetenschap/O&O | 01-06-2017 |
Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Eerdere bekende functies van Peter Sordillo
Bedrijven | Functie | Einde |
---|---|---|
New York University School of Medicine | Corporate Officer/Principal | - |
Weill Cornell Medical College | Corporate Officer/Principal | - |
Opleiding van Peter Sordillo
Columbia College (New York) | Undergraduate Degree |
New York Medical College | Graduate Degree |
New York University | Graduate Degree |
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Commercial Services |